newsfilter
← Latest News
GlobeNewswire·

NexImmune Reports Third Quarter 2022 Financial Results and Announces Strategic Update

Company announces a strategic shift to focus on advancing its AIM Direct Injection (AIM INJ) platform and potential product candidates in oncology and autoimmune diseasesInitiating a corporate resource reallocation to